|
|
|
|
| LEADER |
01077caa a2200313 ir4500 |
| 001 |
NSK01000277948 |
| 003 |
HR-ZaNSK |
| 005 |
20070821133741.0 |
| 008 |
010307s2000 ci ||| ||eng |
| 015 |
|
|
|a HP00-0326
|2 HR
|
| 035 |
|
|
|9 (HR-ZaNSK)278239
|
| 035 |
|
|
|9 (HR-ZaNSK)410307072
|
| 035 |
|
|
|a (HR-ZaNSK)000277948
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 041 |
0 |
|
|a eng
|b hrv
|
| 080 |
|
|
|a 612.463:577.15
|
| 080 |
|
|
|a 577.15:612.463
|
| 100 |
1 |
|
|a Matasić Rossini, Mirela
|
| 245 |
1 |
4 |
|a The decrease of Na superscript plus, K superscript plus - ATPase activity in the renal cortex and medulla induced by enalapril /
|c Mirela Matasić Rossini, Ita Samaržija.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 20 jed
|
| 504 |
|
|
|a Sažetak
|
| 650 |
|
7 |
|a Bubreg
|x Enzimi
|x Djelovanje
|2 nskps
|
| 700 |
1 |
|
|a Samaržija, Ita
|
| 773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 50 (2000), 1 ; str. 49-55
|w nsk.(HR-ZaNSK)000054908
|
| 932 |
|
|
|a da
|
| 981 |
|
|
|p CRO
|z B1/00
|
| 998 |
|
|
|a dimo0103
|a tomp0103
|c vebo0105
|c rjki0110
|
| 886 |
0 |
|
|2 unimarc
|b 00828naa2 2200241 450
|